返回 Agenda
Session 5: Canada Vigilance Update
Session Chair(s)
Melissa Hunt, MSc
Director
Health Canada, Canada
The Canada Vigilance Program is Health Canada's post-market surveillance program that collects and assesses reports of suspected adverse reactions to health products marketed in Canada. This session will focus on what is new within the Canada Vigilance program, developments around the Canada Vigilance database, and ongoing process improvements.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the current state of the Canada Vigilance program
- Explain future directions of the Canada Vigilance program
- State current challenges and opportunities around the quality assurance of adverse reaction reports
Speaker(s)
Canada Vigilance Program Update
Gayatri Jayaraman, PhD, MPH
Health Canada, Canada
Director, Marketed Health Products Directorate
Canada Vigilance Program Update
Bill Wilson
Health Canada , Canada
A/Manager, Data Management and Integrity Section